Residual tumor volume versus extent of resection: Predictors of survival after surgery for glioblastoma

Journal of Neurosurgery

Volumn 121, Issue 5, 2014, Pages 1115-1123

  Grabowski, Matthew M ^a   Recinos, Pablo F ^a   Nowacki, Amy S ^b   Schroeder, Jason L ^a   Angelov, Lilyana ^a   Barnett, Gene H ^a   Vogelbaum, Michael A ^a  

^a Brain Tumor and Neuro oncology Center   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Craniotomy; Extent of resection; Glioblastoma; Oncology; Volumetrics

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL STUDY; CONTRAST ENHANCING RESIDUAL TUMOR VOLUME; FOLLOW UP; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MEDICAL STUDENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL PREDICTION; T2 FLUID ATTENUATED INVERSION RECOVERY RESIDUAL VOLUME; TUMOR VOLUME; BRAIN NEOPLASMS; FEMALE; MALE; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; NEUROSURGICAL PROCEDURES; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84922391306     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2014.7.JNS132449     Document Type: Article

References (23)

1. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45-61, 1994
2. Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, et al: Impact of extent of resection for recurrent glioblastoma on overall survival. Clinical article. J Neurosurg 117:1032-1038, 2012
3. Buckner JC: Factors influencing survival in high-grade gliomas. Semin Oncol 30 (6 Suppl 19):10-14, 2003
4. Central Brain Tumor Registry of the United States: CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2006. Hinsdale, IL: Central Brain Tumor Registry of the United States, 2010 (http://www.cbtrus.org/2010-NPCR-SEER/CBTRUS-WEBREPORT-Final-3-2-10.pdf) [Accessed July 23, 2014]
5. Chaichana KL, Chaichana KK, Olivi A, Weingart JD, Bennett R, Brem H, et al: Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. J Neurosurg 114:587-594, 2011
6. Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, Raza SM, Pascual-Gallego M, Ibrahim A, et al: Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol 16:113-122, 2014
7. Dea N, Fournier-Gosselin MP, Mathieu D, Goffaux P, Fortin D: Does extent of resection impact survival in patients bearing glioblastoma? Can J Neurol Sci 39:632-637, 2012
8. Elster AD, DiPersio DA: Cranial postoperative site: assessment with contrast-enhanced MR imaging. Radiology 174: 93-98, 1990
9. Kanaly CW, Ding D, Mehta AI, Waller AF, Crocker I, Desjardins A, et al: A novel method for volumetric MRI response assessment of enhancing brain tumors. PLoS ONE 6:e16031, 2011
10. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865-874, 1987
11. Kubben PL, Postma AA, Kessels AG, van Overbeeke JJ, van Santbrink H: Intraobserver and interobserver agreement in volumetric assessment of glioblastoma multiforme resection. Neurosurgery 67:1329-1334, 2010
12. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001
13. McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, et al: Independent association of extent of resection with survival in patients with malignant brain astrocytoma. Clinical article. J Neurosurg 110:156-162, 2009
14. Orringer D, Lau D, Khatri S, Zamora-Berridi GJ, Zhang K, Wu C, et al: Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. Clinical article. J Neurosurg 117:851-859, 2012
15. Pang BC, Wan WH, Lee CK, Khu KJ, Ng WH: The role of surgery in high-grade glioma-is surgical resection justified? A review of the current knowledge. Ann Acad Med Singapore 36:358-363, 2007
16. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS: An extent of resection threshold for newly diagnosed glioblastomas. Clinical article. J Neurosurg 115:3-8, 2011
17. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, et al: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044-1056, 1998
18. Sinclair AG, Scoffings DJ: Imaging of the post-operative cranium. Radiographics 30:461-482, 2010
19. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466, 2009
20. Sze G: New applications of MR contrast agents in neuroradiology. Neuroradiology 32:421-438, 1990
21. Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, et al: Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery 70:234-244, 2012
22. Wen PY, Kesari S: Malignant gliomas in adults. N Engl J Med 359:492-507, 2008
23. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al: Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology Working Group. J Clin Oncol 28:1963-1972, 2010